Retrophin Inc. (RTRX): Scopia Capital Adds To Its Stake

Page 6 of 12

Page 6 of 12 – SEC Filing

CUSIP
No.      761299106                

Item 1. (a). Name of Issuer:

Retrophin, Inc. (the Issuer)

(b). Address of Issuers Principal Executive Offices:

12255 El Camino Real, Suite 250

San Diego, CA 92130

Item 2. (a). Name of Person Filing:

Scopia Capital Management LP

Scopia
Management, Inc.

Matthew Sirovich

Jeremy
Mindich

(b). Address or Principal Business Office or, if None, Residence:

Scopia Capital Management LP

152 West 57th
Street, 33rd Floor

New York, NY 10019

Scopia Management, Inc.

Matthew Sirovich

Jeremy Mindich

c/o Scopia Capital Management LP

152 West 57th Street, 33rd Floor

New York, NY 10019

(c). Citizenship:

Scopia Capital Management LP Delaware limited partnership

Scopia Management, Inc. New York corporation

Matthew
Sirovich United States citizen

Jeremy Mindich United States citizen

(d). Title of Class of Securities:

Common Stock, par value $0.0001 per share

(e). CUSIP Number:

761299106

Item 3. If this statement is filed pursuant to §§.240.13d-1(b) or 240.13d-2(b), or (c), check whether the person filing is a:
(a)    ¨ Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
(b)    ¨ Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

Follow Travere Therapeutics Inc. (NASDAQ:TVTX)

Page 6 of 12